![]() |
|
|
Departments of Pharmacology and Physiology (M.A.O., M.W.A.) and Laboratory Animal Medicine (R.B.B.), University of Rochester, School of Medicine and Dentistry; and Biomedical Research Center (J.D.H.), University of Dundee, Ninewells Hospital and Medical School
| |
Abstract |
|---|
|
|
|---|
Distribution of microsomal glutathione transferase (mGST) protein in rat tissues was investigated by immunohistochemistry. Studies on the localization of mGST are of interest because of its involvement in the detoxication and bioactivation of xenobiotics. mGST antigen was detected in the cytoplasm of some hepatocytes and in bile ducts. In kidney, focal staining of mGST was observed in distal tubules and collecting ducts. Cerebral cortical and cerebellar Purkinje neurons showed good immunoreactivity, and nuclear staining was observed in the choroid plexus. The antigen was detected in epithelial cells of respiratory bronchioles and in the crypt cells of the duodenum. Exocrine cells of the pancreas stained for mGST. Nuclear immunostaining for this protein was observed in primary spermatocytes. mGST antigen was detected in the cytoplasm of the adrenal medulla as a granular stain. Leydig and Sertoli cells in testis also stained for the antigen. Distribution of mGST protein differs from that observed with cytosolic transferases and may be important in determining cell-selective susceptibility to xenobiotics.
| |
Introduction |
|---|
|
|
|---|
Glutathione transferases (E.C. 2.5.1.18) catalyze the reaction of glutathione with a range of xenobiotic and endogenous electrophiles (1-3). Multiple GSTs1 exist, and at least 20 GST genes have been identified in the rat (4). Demonstration of the tissue-selective expression and subcellular localization of cytosolic GSTs has improved the understanding of their role in xenobiotic disposition and has provided strategies for assessing tissue-selective cell damage (5, 6).
Both soluble and membrane-bound GSTs have been identified. Cytosolic
GST isoenzymes are a family of homo- and heterodimeric proteins that
are grouped into five classes (
, µ,
,
, and
) based on
primary structure, substrate selectivity, sensitivity to inhibitors,
and immunological properties (2, 7). Soluble GSTs are present in
mitochondria, and a unique
-class (GST 13-13, now called GST T3*-3*)
has been isolated from mitochondrial matrices (8-10).
The role of the GSTs in the detoxication of electrophilic chemicals and
metabolites is well characterized (1). In addition, the
glutathione-dependent bioactivation of a range of
xenobiotics
including vicinal dihaloalkanes (11), isocyanates and
isothiocyanates (12), quinones (13), and haloalkenes (14)
is catalyzed
by GSTs.
Membrane-bound mGST is a homotrimeric protein that is structurally and
immunologically distinct from the cytosolic transferases and is
classified separately (2, 7). mGST differs from the cytosolic GSTs in
that it can be activated several-fold by sulfhydryl reagents, such as
N-ethylmaleimide; this property has been exploited to obtain
purified mGST that is not contaminated with cytosolic GSTs (15). Leukotriene C4 synthesis is catalyzed by a
membrane-bound GST that is distinct from the
N-ethylmaleimide-activatable mGST, as well as from the
-,
µ-,
-,
-, and
-classes of cytosolic GSTs (16).
Human and rat liver microsomal glutathione transferases have been cloned, and the cDNA sequences share 77% identity in the coding region (17). Ontogeny of mGST and the structural organization of human mGST gene have recently been reported (18, 19). Antibodies raised against the human and rat mGSTs cross-react (20).
mGST catalyzes the reaction of glutathione with a range of
electrophilic compounds, and its activity as a selenium-independent peroxidase may be an important cytoprotective function (21). Oxidants
and oxidative stress activate the mGST (22), which may also contribute
to its cytoprotective actions. In addition to its cytoprotective
action, mGST catalyzes the first step in the glutathione- and cysteine
conjugate
-lyase-dependent bioactivation of nephrotoxic haloalkenes
(14). mGST activity is present in various rat organs, and the highest
activity is present in the liver and testes (23). Although activity in
whole-organ homogenates may be relatively low, mGST activity may be
high in some cell populations and may, thereby, contribute to
xenobiotic detoxication or bioactivation. The objective of this study
was to examine the cellular localization of mGST in various rat organs
by immunohistochemistry.
Methods
Tissue Preparations. Fischer 344 rats (200-250 g; Charles River Breeding Laboratories, Inc., Wilmington, MA) were used. Rats were anesthetized with sodium pentobarbital:chloral hydrate (50 mg/kg:250 mg/kg, ip) and perfused through the left ventricle with PBS, followed by 10% neutral-buffered formalin. Organs were removed, fixed in 10% buffered formalin, and embedded in paraffin. Sections (5 µm) were prepared and mounted on poly-L-lysine-coated slides.
Western Blotting.
mGST was purified from the microsomal fraction of human liver by a
combination of hydroxyapatite, gel filtration, and CM-cellulose chromatography (20). Female New Zealand white rabbits were each initially immunized with 200 µg of purified mGST in complete
Freund's adjuvant, which was followed 6 weeks later by another
inoculation with 200 µg of mGST in incomplete Freund's adjuvant
(24). Animals were bled 2 weeks after the second inoculation, and serum
was prepared. After the addition of sodium azide to a final
concentration of 0.1%, serum was stored at
70°C until used.
Microsomal fractions were prepared as described previously (25).
Protein samples (2-10 µg) were loaded on 10% (w/v) polyacrylamide
gels and separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis with a Protein mini-gel apparatus (Bio-Rad
Laboratories, Richmond, CA). Proteins were transferred to
nitrocellulose membranes (Bio-Rad Laboratories) with a LKB Transphor
electroblotting unit (LKB, Gaithersburg, MD). Membranes were treated
with blocking solution [7.5% (w/v) nonfat dry milk in 20 mM Tris HCl,
150 mM NaCl, and 0.15% (w/v) Tween 20 (pH 7.4)] for 16 hr, followed
by incubation with primary antibody (diluted 1:1,000 in blocking
solution) for 7 hr. Membranes were incubated for 1 hr with alkaline
phosphatase-linked goat anti-rabbit secondary antibody diluted 1:1,000
in a mixture of 20 mM Tris HCl, 150 mM NaCl, and 0.15% (w/v) Tween 20 (pH 7.4). All incubations were conducted at room temperature, and
membranes were washed three times with a mixture of 20 mM Tris HCl, 150 mM NaCl, and 0.15% (w/v) Tween 20 (pH 7.4) for 10 min between each
step. Immunoreactive bands were detected with 0.3 mg/ml nitro blue
tetrazolium and 0.15 mg/ml 5-bromo-4-chloro-3-indoloyl phosphate in 100 mM Tris buffer (pH 9.5) containing 5 mM MgCl2.
Immunohistochemistry. The avidin-biotin complex staining method (Vector Laboratories, Inc., Burlingame, CA) was used according to the manufacturer's directions to localize mGST in paraffin-embedded tissue sections. Primary antibodies or preimmune serum were diluted 1:1000 in a solution of 0.4% Triton X-100 and 1% bovine serum albumin in PBS. Secondary antibodies were diluted in PBS.
Paraffin was removed from the sections by immersion in xylene, and sections were rehydrated by immersion in graded, decreasing concentrations of ethanol in water. Endogenous peroxidase activity was quenched by incubating the slides for 5 min in a solution of 3% H2O2 and 10% methanol in PBS; sections were washed twice with a solution of 0.02% Triton X-100 in PBS for 15 min. Slides were incubated with preimmune serum or primary antibodies (1:1,000) for 48 hr at 4°C, followed by incubation with the biotinylated goat anti-rabbit secondary antibody (Vector Laboratories) for 1 hr at room temperature. Horseradish-peroxidase-conjugated avidin-biotin complex (Vectastain Elite Kit, Vector Laboratories) was diluted and prepared according to the manufacturer's directions, and sections were incubated in this mixture for 1 hr. Between each step, slides were incubated twice with a solution of 0.02% Triton X-100 in PBS for 15 min at room temperature. Before detection of the antigen, the slides were rinsed three times with 0.05 M Tris-buffered saline (pH 7.2). Detection with diaminobenzidine or 3-amino-9-ethylcarbazole was done according to the manufacturer's directions (Vector Laboratories). Slides stained with diaminobenzidine were counterstained with hematoxylin, dehydrated, and mounted in an organic mounting medium (Permount; Fisher Scientific, Fair Lawn, NJ); slides treated with 3-amino-9-ethylcarbazole were also counterstained with hematoxylin, but were mounted in an aqueous mount (Aqua-polymount; Polysciences, Inc., Warrington, PA).| |
Results and Discussion |
|---|
|
|
|---|
This study represents the first immunohistochemical description of the comparative distribution of mGST protein in rat tissues. mGST antigen was detected in differing amounts in the organs studied by immunoblotting and immunohistochemistry.
Immunoblotting studies with human anti-mGST antibodies showed the presence of a single protein band of identical mobility in microsomal fractions from rat liver, testis, kidney, and lung (fig. 1). The immunoreactive band displayed a mobility consistent with its identity as mGST and was estimated to have a molecular mass of ~17 kDa; the calculated molecular mass of rat liver mGST is 17,430 Da (17). Furthermore, antibodies yielded a single band in the immunoblots, indicating selectivity for mGST. Antibodies raised against the mGST do not cross-react with cytosolic GSTs (15). (Because the amount of mGST protein in the tissues studied differed, the amount of protein applied to the gel varied with the tissue being studied; fig. 1 cannot be used to compare the relative amounts of mGST in various tissues.)
|
Cellular localization of mGST protein in various rat organs was studied by immunohistochemistry. A comparison of the localization of mGST found in this study and that reported for other rat and human cytosolic GSTs is summarized in table 1.
|
In the liver, mGST antigen was demonstrable as a faintly granular
cytoplasmic material in most, but not all, hepatocytes (fig. 2A). Staining was occasionally intense in
individual hepatocytes (fig. 2E, arrow), but
adjacent clusters of hepatocytes seemed to lack detectable antigen
(fig. 2A, arrow). Staining tended to be more
intense in centrilobular regions than in periportal regions. The reason
for the uneven distribution of mGST protein in hepatocytes is not
clear. mGST was detected in the cytoplasm and not in nuclei of
hepatocytes, which is in agreement with previously reported results
with human tissues (26). Both nuclear and cytoplasmic detection of
GST-
in hepatocytes has been previously reported (27, 28). In the
portal triad, cytoplasmic components of the bile duct epithelium were
well stained (fig. 2C). GSTs have the capacity to bind a
wide range of lipophilic compounds, including bile acids and bilirubin
(29, 30). mGST in the biliary epithelium may serve as a carrier protein
for the transport of such molecules, as well as function to detoxify
xenobiotics. Nonspecific staining was not observed in sections
incubated with preimmune serum (fig. 2, B, D, and
F).
|
Immunohistochemical observation of mGST protein in hepatocytes is
consistent with the observation that hepatic mGST activity exerts a
cytoprotective function by providing glutathione-dependent detoxication
against lipid peroxidation (21, 31). Hepatic mGST also catalyzes the
first step in the glutathione- and
-lyase-dependent bioactivation
of nephrotoxic haloalkenes. Also, in rat hepatocytes, 85% of
glutathione-conjugate formation with chlorotrifluoroethene as the
substrate is catalyzed by mGST (32). Hexafluoropropene is converted to
S-(1,1,2,3,3,3-hexafluoropropyl)glutathione in rat hepatic
cytosolic fractions and to
S-(1,2,3,3,3-pentafluoropropenyl)glutathione in rat hepatic
microsomal fractions, but total conjugate formation is greater in
microsomes than in cytosol (33).
Other immunohistochemical studies show the presence of
-, µ-, and
-class GSTs in rat liver hepatocytes. Like mGSTs, staining was more
intense in the centrilobular region than in the midzonal or perioportal
regions (34). GST-
is not seen in adult hepatocytes, but, like µ-
and
-class GSTs, it is expressed in biliary epithelium (27, 28, 35).
GST-
is not present in bile ducts (28).
In the renal cortex, the most intense staining for mGST antigen was observed in the distal convoluted tubules (fig. 3). Faint staining was observed in some glomerular cells, and the proximal convoluted tubules demonstrated light apical staining, but none was demonstrable in the brush border (fig. 3A). Collecting ducts in the cortex and medulla were well stained (fig. 3C). Thick portions of the loop of Henle were stained intensely (fig. 3E). Nonspecific staining was not observed in sections incubated with preimmune serum (fig. 3, B, D, and F).
|
GST-
is selectively expressed in renal proximal tubules and in the
thick descending section of the loop of Henle, whereas GST-µ and -
are expressed selectively in the thin loop of Henle, distal convoluted
tubules, and collecting ducts (5, 28, 35-37). Focal localization of
mGST antigen in the distal tubules and collecting ducts and of GST-
in the proximal tubules demonstrates the ubiquitous distribution of
GSTs throughout the nephron.
The presence of GSTs in the kidney is well established (38). Renal glutathione-conjugate formation has been detected in isolated rabbit renal proximal tubules with chlorotrifluoroethene as the substrate, although the enzyme that catalyzes the reaction was not identified (39). Renal cytosolic fractions, but not renal microsomal fractions, catalyze the conversion of hexafluoropropene to S-(1,1,2,3,3,3-hexafluoropropyl)glutathione, but S-(1,2,3,3,3-pentafluoropropenyl)glutathione formation was not detected in kidney cytosol or microsomes.
The release of GST-
from its proximal tubular location and its
detection in urine has previously been used as a diagnostic measure of
renal tubular damage in cyclosporin-induced nephrotoxicity (40, 41).
Use of GST-
in urine, as a marker of renal tubular injury, has also
been reported (42, 43).
S-(1,2-Dichlorovinyl)-L-cysteine is selectively
toxic to the S3 segment of the proximal tubule and is an
example of renal toxins that target specific segments of the renal
tubules, leaving other segments unharmed. Selective markers for renal
tubular injury are useful diagnostic tools for such toxins. As has been
demonstrated for GST-
and -
, focal localization of mGST makes it
a potentially suitable candidate as a marker for distal tubular injury;
in addition the lack of immunoreactivity of anti-mGST antibodies with
cytosolic GSTs (15) is a property that could be exploited to design
sensitive assays that would distinguish it from other GSTs also used as
markers.
mGST protein was also detected in the brain (fig. 4). Choroid epithelial cells were intensely stained (fig. 4A, arrow), and abundant antigen was detected in both the nucleus and cytoplasm. Neuronal nuclei in the cerebral cortex were well stained (fig. 4C), as were cerebellar Purkinje neurons and the molecular-layer neurophil (fig. 4E). Nonspecific staining was not observed in sections incubated with preimmune serum (fig. 4, B, D, and F).
|
In human brains, GST-
and -
have not been detected in neurons,
but weak staining is observed with GST-
in glial cells (27, 28, 44).
However, studies with rat brain show nuclear localization of GST-
in
Purkinje cells and neurons in the brainstem, hippocampus, and cerebral
cortex (45). Immunohistochemical studies with rat µ-class GSTs show
that the protein is localized in the glial cells lining the ventricles
and in astrocyte endfeet and processes (46).
GST activity is much higher in cultured chick astrocytes than in neurons or forebrain (47). Whole-brain mGST activity is much lower (~6%) than liver mGST activity (23).
Glutathione-dependent conjugation in brain cytosol has been demonstrated with the neurotoxin acrylamide (48). There is also evidence that brain GSTs can bind hormones and neurotransmitters (46). The role of mGST in the nucleus is to be determined. Glutathione peroxidase activity of GSTs has been postulated to play a role in the detoxication of peroxidized DNA, and mGST has been shown to protect against lipid peroxidation. mGST may play a significant role in detoxifying peroxides in the nucleus, because selenium-dependent glutathione peroxidase activity is low in this organelle (49, 50). Bennett et al. (51) have also reported that the DNA-binding protein, protein BA that colocalizes with U-snRNPs in the cell nucleus is a glutathione transferase.
In lung tissue, there was scanty, focal presence of antigen in the epithelial cells of the terminal respiratory bronchioles, most notably in the apical portions, and alveolar epithelial cells showed little detectable cytoplasmic antigen (fig. 5A). Nonspecific staining was not observed in sections incubated with preimmune serum (fig. 5B).
|
mGST activity in lung is 12% of that found in liver (23). Lung mGST may play a role in the bioactivation of xenobiotics: Patel et al. (52) found that, of the extrahepatic tissues studied, lung microsomes had the highest activity toward dichloroacetylene, a neurotoxin, nephrotoxin, and nephrocarcinogen. Activity was not observed in the lung cytosol.
Proteins corresponding to
- and µ-class GSTs have been purified
from rat lung (53). GST-
protein was not detected in the epithelial
cells of the lung or bronchi (28). In contrast, Anttila et
al. (54) reported localization of all GST classes in the bronchial
epithelium. Others have detected GST-
in ciliated epithelial cells
and GST-
, -µ, and -
in Clara cells (55).
In the intestinal tract, duodenal tissue was also examined for the presence of mGST antigen. Staining was most intense in the apical portions (brush border) of the enteric epithelial cells, particularly in the cryptal areas (fig. 6A). Nonspecific staining was not observed in sections incubated with preimmune serum (fig. 6B). Specific activity of mGST in rat intestine is 48% of that present in the liver (23).
|
In the rat intestine, GST activity is highest in the duodenum and
jejunum (56, 57). GST-
is expressed at significant levels in the
duodenum (28).
In pancreatic tissue, the Islets of Langerhans lacked antigen (fig. 7A). Exocrine epithelial cells contained some antigen, most notably in the apical portions of epithelial cells. Nonspecific staining was not observed in sections incubated with preimmune serum (fig. 7B).
|
GST-
and GST-
antigens have not been detected in the Islets of
Langerhans (27, 35). GST-
has been detected in the cytoplasm of
acinar cells, whereas GST-
is present in both the cytoplasm and some
nuclei of these cells in rat pancreas (58).
Cells of the adrenal cortex showed little staining, but medullary cells contained variable amounts of faintly staining granular material in the cytoplasms (fig. 8A). Occasional cells contained abundant antigen, but adjacent cells showed scanty stainable material. Nonspecific staining was not observed in sections incubated with preimmune serum (fig. 8B). Specific activity of mGST in rat adrenal is 41% of that found in the liver (23).
|
GST-
protein is found in the zona reticularis of the adrenal cortex,
but not in the outer layers of the cortex or medulla (28). GST-
was
detected faintly in both layers (27).
In the testes, the interstitial cells showed modest cytoplasmic and nuclear staining (fig. 9A). All stages of sperm-cell maturation were stained in the seminiferous tubules, and staining was pronounced in the nuclei of primary spermatocytes. Nonspecific staining was not observed in sections incubated with preimmune serum (fig. 9B).
|
Activity studies show that the specific activity of mGST in rat testis is similar to that in the liver (23), but a physiological role for mGST in the testis has not been established. Peroxidative DNA damage has been observed in proliferating cells (3) and, because mGST shows peroxidase activity (59), it is possible to speculate that testicular mGST may function to reduce damage to DNA caused by oxidative stress.
Immunohistochemical studies with cytosolic GSTs show the presence of
all GST classes in Leydig cells in the testis; GST-
and GST-µ were
detected in Sertoli cells, whereas all stages of sperm-cell maturation
were unreactive to antibodies against
-,
-, or µ-class GSTs
(27, 28, 60, 61). Distribution of GSTs along the rat epididymis seems
to be region-specific; recent evidence shows selective expression of
GST-
in basal cells of the epididymal epithelium (62). Basal cells
have been proposed to play an active role in detoxication in the
epididymis, thus further demonstrating the cytoprotective role that
GSTs may play in the testis. Finally, the presence of µ- and
-class GSTs in testicular microsomes has recently been reported
(63).
Present studies show that the distribution of mGST protein differs from
that of cytosolic GSTs that have been studied. Both mGST and cytosolic
GSTs play important roles in xenobiotic detoxication and bioactivation.
As described previously, peroxidative activity of mGST may exert a
detoxification function in testes. mGST is important in the
bioactivation of nephrotoxic haloalkenes. Several haloalkenes are
selective nephrotoxins and undergo glutathione and cysteine conjugate
-lyase-dependent bioactivation (14, 64, 65). Biotransformation of
haloalkenes to glutathione conjugates is preferentially catalyzed by
hepatic mGST (32). Present findings show the presence of small amounts
of mGST antigen in renal proximal tubules, which is consistent with the
observation that mGST activity is much lower in the kidney than in the
liver (23). As described previously, studies with chlorotrifluoroethene
show that ~85% of hepatic glutathione conjugate formation is
catalyzed by mGST (32).
Immunohistochemical studies reported herein demonstrate unique patterns
of distribution of mGST protein across organs and show that the
distribution pattern seen with mGST differs from the patterns seen with
most cytosolic transferases, although there are some similarities
between the distribution of mGST and GST-
. Distribution of GST
activities may play a role in determining the susceptibility of a
tissue or cell type to different xenobiotics, because mGST and
cytosolic GSTs have different, but overlapping, substrate
selectivities.
| |
Footnotes |
|---|
Received June 21, 1996; accepted September 27, 1996.
This study was supported by the National Institute of Environmental Health Sciences Grant ES03127 (to M.W.A.).
Send reprint requests to: Dr. M. W. Anders, Department of Pharmacology and Physiology, University of Rochester, 601 Elmwood Avenue, Box 711, Rochester, NY 14642.
| |
Abbreviations |
|---|
Abbreviations used are: GST, glutathione transferase; mGST, microsomal glutathione transferase; PBS, phosphate-buffered saline.
| |
References |
|---|
|
|
|---|
| 1. | L. F. Chasseaud: The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. Adv. Cancer Res. 29, 175-274 (1979)[Medline]. |
| 2. | B. Mannervik and M. Widersten: Human glutathione transferases: classification, tissue distribution, structure, and functional properties. In "Advances in Drug Metabolism in Man" (G. M. Pacifici and G. N. Fracchia, eds.), pp. 407-459. Commission of the European Communities, Luxembourg, 1995. |
| 3. | B. Ketterer and L. G. Christodoulides: Enzymology of the cytosolic glutathione S-transferases. Adv. Pharmacol. 27, 37-69 (1994). |
| 4. | J. D. Hayes and D. J. Pulford: The glutathione S-transferase supergene family: regulation of GST and the contribution of isoenzymes to cancer chemoprotection and drug resistance. CRC Crit. Rev. Biochem. Mol. Biol. 30, 445-600 (1995). |
| 5. |
D. J. Harrison,
R. Kharbanda,
D. S. Cunningham,
L. I. McLellan, and
J. D. Hayes:
Distribution of glutathione S-transferase isoenzymes in human kidney: basis for possible markers of renal injury.
J. Clin. Pathol.
42,
624-628 (1989) |
| 6. | A. Sundberg, E. L. Appelkvist, G. Dallner, and R. Nilsson: Glutathione transferases in the urine: sensitive methods for detection of kidney damage induced by nephrotoxic agents in humans. Environ. Health Perspect. 102 (Suppl. 3), 293-296 (1994). |
| 7. |
B. Mannervik and
U. H. Danielson:
Glutathione transferases structure and catalytic activity.
CRC Crit. Rev. Biochem.
23,
281-334 (1988).
|
| 8. | P. Kraus: Resolution, purification and some properties of three glutathione transferases from rat liver mitochondria. Hoppe-Seyler's Z. Physiol. Chem. 361, 9-15 (1980)[Medline]. |
| 9. | C. M. Ryle and T. J. Mantle: Studies on the glutathione S-transferase activity associated with rat liver mitochondria. Biochem. J. 222, 553-556 (1984)[Medline]. |
| 10. | J. M. Harris, D. J. Meyer, B. Coles, and B. Ketterer: A novel glutathione transferase (13-13) isolated from the matrix of rat liver mitochondria having structural similarity to class theta enzymes. Biochem. J. 278, 137-141 (1991). |
| 11. | F. P. Guengerich: Metabolism and genotoxicity of dihaloalkanes. Adv. Pharmacol. 27, 211-236 (1994). |
| 12. | T. A. Baillie and K. Kassahun: Reversibility in glutathione-conjugate formation. Adv. Pharmacol. 27, 165-183 (1994). |
| 13. | T. J. Monks and S. S. Lau: Glutathione conjugates as a mechanism for the transport of reactive metabolites. Adv. Pharmacol. 27, 183-210 (1994). |
| 14. |
W. Dekant,
S. Vamvakas, and
M. W. Anders:
Formation and fate of nephrotoxic and cytotoxic glutathione S-conjugates: cysteine conjugate -lyase pathway.
Adv. Pharmacol.
27,
115-162 (1994).
|
| 15. | C. Andersson, E. Mosialou, R. Weinander, and R. Morgenstern: Enzymology of microsomal glutathione S-transferase. Adv. Pharmacol. 27, 19-35 (1994). |
| 16. | M. Söderström, S. Hammarström, and B. Mannervik: Leukotriene C synthase in mouse mastocytoma cells. Biochem. J. 250, 713-718 (1988)[Medline]. |
| 17. |
J. L. DeJong,
R. Morgenstern,
H. Jörnvall,
J. W. DePierre, and
C.-P. D. Tu:
Gene expression of rat and human microsomal glutathione S-transferases.
J. Biol. Chem.
263,
8430-8436 (1988) |
| 18. | G. Lundqvist and R. Morgenstern: Ontogenesis of rat liver microsomal glutathione transferase. Biochem. Pharmacol. 50, 421-423 (1995)[Medline]. |
| 19. | M. J. Kelner, M. N. Stokely, N. E. Stovall, and M. A. Montoya: Structural organization of the human microsomal glutathione S-transferase gene (GST12). Genomics, in press. |
| 20. | L. I. McLellan, C. R. Wolf, and J. D. Hayes: Human microsomal glutathione S-transferase. Its involvement in the conjugation of hexachloro-1,3-butadiene with glutathione. Biochem. J. 258, 87-93 (1989)[Medline]. |
| 21. | E. Mosialou, G. Ekstrom, A. E. P. Adang, and R. Morgenstern: Evidence that rat liver microsomal glutathione transferase is responsible for glutathione-dependent protection against lipid peroxidation. Biochem. Pharmacol. 45, 1645-1651 (1993)[Medline]. |
| 22. |
Y. Aniya and
M. W. Anders:
Activation of rat liver microsomal glutathione S-transferase by reduced oxygen species.
J. Biol. Chem.
264,
1998-2002 (1989) |
| 23. | R. Morgenstern, G. Lundqvist, G. Andersson, L. Balk, and J. W. DePierre: The distribution of microsomal glutathione transferase among different organelles, different organs, and different organisms. Biochem. Pharmacol. 33, 3609-3614 (1984)[Medline]. |
| 24. | J. D. Hayes and T. J. Mantle: Use of immuno-blot techniques to discriminate between the glutathione S-transferase Yf, Yk, Ya, Yn/Yb and Yc subunits and to study their distribution in extrahepatic tissues. Biochem. J. 233, 779-788 (1986)[Medline]. |
| 25. | E. Tanaka and M. W. Anders: Biosynthesis of S-(2-chloro-1,1,2-trifluoroethyl)glutathione in rat and human hepatocytes and in Hep G2 cells. Drug Metab. Dispos. 23, 48-54 (1995)[Abstract]. |
| 26. |
P. C. Hayes,
D. J. Harrison,
I. A. D. Bouchier,
L. I. McLellan, and
J. D. Hayes:
Cytosolic and microsomal glutathione S-transferase isoenzymes in normal human liver and intestinal epithelium.
Gut
30,
854-859 (1989) |
| 27. | J. A. H. Campbell, A. V. Corrigall, A. Guy, and R. E. Kirsch: Immunohistologic localization of alpha, mu, and pi class glutathione S-transferases in human tissues. Cancer 67, 1608-1613 (1991)[Medline]. |
| 28. |
A. G. M. Sundberg,
R. Nilsson,
E.-L. Appelkvist, and
G. Dallner:
Immunohistochemical localization of and class glutathione transferases in normal human tissues.
Pharmacol. Toxicol.
72,
321-331 (1993)[Medline].
|
| 29. | K. Kamisaka, I. Listowsky, Z. Gatmaitan, and I. M. Arias: Interactions of bilirubin and other ligands with ligandin. Biochemistry 14, 2175-2180 (1975)[Medline]. |
| 30. |
H. Maruyama and
I. Listowsky:
Preferential binding of steroids by anionic forms of rat glutathione S-transferase.
J. Biol. Chem.
259,
12449-12455 (1984) |
| 31. | E. Mosialou and R. Morgenstern: Activity of rat liver microsomal glutathione transferase towards products of lipid peroxidation and studies on the effect of inhibitors on glutathione-dependent protection against lipid peroxidation. Arch. Biochem. Biophys. 275, 289-294 (1989)[Medline]. |
| 32. | S. J. Hargus, M. E. Fitzsimmons, Y. Aniya, and M. W. Anders: Stereochemistry of the microsomal glutathione S-transferase catalyzed addition of glutathione to chlorotrifluoroethene. Biochemistry 30, 717-721 (1991)[Medline]. |
| 33. | M. Koob and W. Dekant: Metabolism of hexafluoropropene. Evidence for bioactivation by glutathione conjugate formation in the kidney. Drug. Metab. Dispos. 18, 911-916 (1990)[Abstract]. |
| 34. |
J. A. Redick,
W. B. Jakoby, and
J. Baron:
Immunohistochemical localization of glutathione S-transferases in livers of untreated rats.
J. Biol. Chem.
257,
15200-15203 (1982) |
| 35. | P. Terrier, A. J. Townsend, J. M. Coindre, T. J. Triches, and K. H. Cowan: An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am. J. Pathol. 137, 845-853 (1990)[Abstract]. |
| 36. |
B. Rozell,
H.-A. Hansson,
C. Guthenberg,
M. K. Tahir, and
B. Mannervik:
Glutathione transferases of classes , µ and show selective expression in different regions of rat kidney.
Xenobiotica
23,
835-849 (1993)[Medline].
|
| 37. | L. H. Overby, S. Gardlik, R. M. Philpot, and C. J. Serabjit-Singh: Unique distribution profiles of glutathione S-transferases in regions of kidney, ureter, and bladder of rabbit. Lab. Invest. 70, 468-478 (1994)[Medline]. |
| 38. | M. W. Anders and W. Dekant: Renal xenobiotic metabolism: Role in bioactivation of nephrotoxic xenobiotics. In "Renal Disposition and Nephrotoxicity of Xenobiotics" (M. W. Anders, W. Dekant, D. Henschler, H. Oberleithner and S. Silbernagl, eds.), pp. 155-183. Academic Press, San Diego, 1993. |
| 39. | C. D. Hassall, A. J. Gandolfi, R. C. Duhamel, and K. Brendel: The formation and biotransformation of cysteine conjugates of halogenated ethylenes by rabbit renal tubules. Chem.-Biol. Interact. 49, 283-297 (1984)[Medline]. |
| 40. | L. Bäckman, E.-L. Appelkvist, O. Ringdén, and G. Dallner: Glutathione transferase in the urine: a marker for post-transplant tubular lesions. Kidney Int. 33, 571-577 (1988)[Medline]. |
| 41. | L. Bäckman, E. L. Appelkvist, O. Ringdén, and G. Dallner: Urinary levels of basic glutathione transferase as an indicator of proximal tubular damage in renal transplant recipients. Transplant. Proc. 21, 1514-1516 (1989)[Medline]. |
| 42. | A. G. Sundberg, E. L. Appelkvist, L. Backman, and G. Dallner: Urinary pi-class glutathione transferase as an indicator of tubular damage in the human kidney. Nephron 67, 308-316 (1994)[Medline]. |
| 43. | A. G. Sundberg, E. L. Appelkvist, L. Backman, and G. Dallner: Quantitation of glutathione transferase-pi in the urine by radioimmunoassay. Nephron 66, 162-169 (1994)[Medline]. |
| 44. | P. J. Carder, R. Hume, A. A. Fryer, R. C. Strange, J. Lauder, and J. E. Bell: Glutathione S-transferase in human brain. Neuropathol. Appl. Neurobiol. 16, 293-303 (1990)[Medline]. |
| 45. | J. A. Johnson, A. El Barbary, S. E. Kornguth, J. F. Brugge, and F. L. Siegel: Glutathione S-transferase isoenzymes in rat brain neurons and glia. J. Neurosci. 13, 2013-2023 (1993)[Abstract]. |
| 46. | M. Abramovitz, H. Homma, S. Ishigaki, F. Tansey, W. Cammer, and I. Listowsky: Characterization and localization of glutathione-S-transferases in rat brain and binding of hormones, neurotransmitters, and drugs. J. Neurochem. 50, 50-57 (1988)[Medline]. |
| 47. | T. K. Makar, M. Nedergaard, A. Preuss, A. S. Gelbard, A. S. Perumal, and A. J. L. Cooper: Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes plan an important role in antioxidative processes in the brain. J. Neurochem. 62, 45-53 (1994)[Medline]. |
| 48. | R. Dixit, H. Mukhtar, P. K. Seth, and C. R. Krishna Murti: Conjugation of acrylamide with glutathione catalysed by glutathione-S-transferases of rat liver and brain. Biochem. Pharmacol. 30, 1739-1744 (1981)[Medline]. |
| 49. | B. Ketterer and D. J. Meyer: Glutathione transferases: a possible role in the detoxication and repair of DNA and lipid hydroperoxides. Mutat. Res. 214, 33-40 (1989)[Medline]. |
| 50. | E. Mosialou, F. Piemonte, C. Andersson, R. M. E. Vos, P. J. Van Bladeren, and R. Morgenstern: Microsomal glutathione transferase: lipid-derived substrates and lipid dependence. Arch. Biochem. Biophys. 320, 210-216 (1995)[Medline]. |
| 51. |
C. F. Bennett,
D. L. Spector, and
L. C. Yeoman:
Nonhistone protein BA is a glutathione S-transferase localized to interchromatinic regions of the cell nucleus.
J. Cell Biol.
102,
600-609 (1986) |
| 52. | N. Patel, G. Birner, W. Dekant, and M. W. Anders: Glutathione-dependent biosynthesis and bioactivation of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cystine, the glutathione and cysteine S-conjugates of dichloroacetylene, in rat tissues and subcellular fractions. Drug Metab. Dispos. 22, 143-147 (1994)[Abstract]. |
| 53. | C. A. Partridge, S. V. Singh, T. D. Hong, C. Theodore, D. D. Dao, and Y. C. Awasthi: Rat lung glutathione S-transferases: subunit structure and the interrelationships with the liver enzymes. Int. J. Biochem. 17, 331-340 (1985)[Medline]. |
| 54. |
S. Anttila,
A. Hirvonen,
H. Vainio,
K. Husgafvel-Pursiainen,
J. D. Hayes, and
B. Ketterer:
Immunocytochemical localization of glutathione S-transferases in human lung.
Cancer Res.
53,
5643-5648 (1993) |
| 55. |
D. B. Coursin,
H. P. Cihla,
T. D. Oberley, and
L. W. Oberley:
Immunolocalization of antioxidant enzymes and isozymes of glutathione S-transferase in normal rat lung.
Am. J. Physiol.
263,
L679-L691 (1992) |
| 56. | L. M. Pinkus, J. N. Ketley, and W. B. Jakoby: The glutathione S-transferases as a possible detoxication system of rat intestinal epithelium. Biochem. Pharmacol. 26, 2359-2363 (1977)[Medline]. |
| 57. |
G. Clifton and
N. Kaplowitz:
The glutathione S-transferases of the small intestine in the rat.
Cancer Res.
37,
788-791 (1977) |
| 58. |
J. M. Daly,
L. B. G. Tee,
P. S. Oates,
R. G. H. Morgan, and
C. T. Yeoh:
Glutathione S-transferase (µ class) as an early marker of azaserine-induced foci in the rat pancreas.
Carcinogenesis
12,
1237-1240 (1991) |
| 59. | C. C. Reddy, C.-P. D. Tu, J. R. Burgess, C.-Y. Ho, R. W. Scholz, and E. J. Massaro: Evidence for the occurrence of selenium-independent glutathione peroxidase activity in rat liver microsomes. Biochem. Biophys. Res. Commun. 101, 970-978 (1981)[Medline]. |
| 60. |
J. P. Veri,
L. Hermo, and
R. Robaire:
Immunocytochemical localization of glutathione S-transferase Yo subunit in the rat testis and epididymis.
J. Androl.
15,
415-434 (1994) |
| 61. | S. Papp, B. Robaire, and L. Hermo: Immunocytochemical localization of the Ya, Yc, Yb1, and Yb2 subunits of glutathione S-transferase in the testis and epididymis of adult rats. Microsc. Res. Tech. 30, 1-23 (1995)[Medline]. |
| 62. | B. Robaire and R. S. Viger: Regulation of epididymal epithelial cell functions. Biol. Reprod. 52, 226-236 (1995)[Abstract]. |
| 63. |
M. Shimoji and
Y. Aniya:
Glutathione S-transferases in rat testis microsomes: comparison with liver transferase.
J. Biochem.
115,
1128-1134 (1994) |
| 64. | W. Dekant, M. W. Anders, and T. J. Monks: Bioactivation of halogenated xenobiotics by S-conjugate formation. In "Renal Disposition and Nephrotoxicity of Xenobiotics" (M. W. Anders, W. Dekant, D. Henschler, H. Oberleithner and S. Silbernagl, eds.), pp. 187-215. Academic Press, San Diego, 1993. |
| 65. | M. W. Anders, W. Dekant, and S. Vamvakas: Glutathione-dependent bioactivation of xenobiotics. In "Biothiols" (L. Packer and E. Cadenas, eds.), pp. 135-163. Marcel Dekker, New York, 1995. |
This article has been cited by other articles:
![]() |
Y. Ji and B. M. Bennett Activation of Microsomal Glutathione S-Transferase by Peroxynitrite Mol. Pharmacol., January 1, 2003; 63(1): 136 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. M. Lantum, R. B. Baggs, D. M. Krenitsky, P. G. Board, and M. W. Anders Immunohistochemical Localization and Activity of Glutathione Transferase Zeta (GSTZ1-1) in Rat Tissues Drug Metab. Dispos., June 1, 2002; 30(6): 616 - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Lash and J. C. Parker Hepatic and Renal Toxicities Associated with Perchloroethylene Pharmacol. Rev., May 11, 2001; (2001) 2. [Abstract] [Full Text] |
||||
![]() |
M. A. Otieno and T. W. Kensler A Role for Protein Kinase C-{{delta}} in the Regulation of Ornithine Decarboxylase Expression by Oxidative Stress Cancer Res., August 1, 2000; 60(16): 4391 - 4396. [Abstract] [Full Text] |
||||
![]() |
S. Dore, M. Takahashi, C. D. Ferris, L. D. Hester, D. Guastella, and S. H. Snyder Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury PNAS, March 2, 1999; 96(5): 2445 - 2450. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-J. Jakobsson, J. A. Mancini, D. Riendeau, and A. W. Ford-Hutchinson Identification and Characterization of a Novel Microsomal Enzyme with Glutathione-dependent Transferase and Peroxidase Activities J. Biol. Chem., September 5, 1997; 272(36): 22934 - 22939. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Lash and J. C. Parker Hepatic and Renal Toxicities Associated with Perchloroethylene Pharmacol. Rev., June 1, 2001; 53(2): 177 - 208. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||